BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 15764874)

  • 1. Indium-111 pentetreotide imaging of carcinoid tumor of the thymus.
    Borrero CG; McCook B; Mountz JM
    Clin Nucl Med; 2005 Apr; 30(4):218-21. PubMed ID: 15764874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of In-111 pentetreotide scintigraphy in the diagnosis of a midgut carcinoid causing Cushing's syndrome.
    Segu VB; Mahvi DM; Wilson MA; Hale SJ; Warner TF; Meredith M; Shenker Y
    Eur J Endocrinol; 1997 Jul; 137(1):79-83. PubMed ID: 9242206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of radioguided surgery with [111In]-pentetreotide in the management of an ACTH-secreting bronchial carcinoid causing ectopic Cushing's syndrome.
    Grossrubatscher E; Vignati F; Dalino P; Possa M; Belloni PA; Vanzulli A; Bramerio M; Marocchi A; Rossetti O; Zurleni F; Loli P
    J Endocrinol Invest; 2005 Jan; 28(1):72-8. PubMed ID: 15816375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recurrent ectopic adrenocorticotropic hormone producing thymic carcinoid detected with octreotide imaging.
    Silva F; Vázquez-Sellés J; Aguilö F; Vázquez G; Flores C
    Clin Nucl Med; 1999 Feb; 24(2):109-10. PubMed ID: 9988068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Thymic carcinoid tumor revealed by a Cushing's syndrome: usefulness of positron emission tomography].
    Gomard-Mennesson E; Sève P; De La Roche E; Collardeau-Frachon S; Lombard-Bohas C; Broussolle C
    Rev Med Interne; 2008 Sep; 29(9):751-3. PubMed ID: 18304700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [18F]fluoro-2-deoxy-D-glucose ([18F]FDG) positron emission tomography imaging of thymic carcinoid tumor presenting with recurrent Cushing's syndrome.
    Markou A; Manning P; Kaya B; Datta SN; Bomanji JB; Conway GS
    Eur J Endocrinol; 2005 Apr; 152(4):521-5. PubMed ID: 15817906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis and radioguided surgery with 111In-pentetreotide in a patient with paraneoplastic Cushing's syndrome due to a bronchial carcinoid.
    Mansi L; Rambaldi PF; Panza N; Esposito D; Esposito V; Pastore V
    Eur J Endocrinol; 1997 Dec; 137(6):688-90. PubMed ID: 9437238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Gammagraphy of somatostatin receptors in an ACTH secreting thymic carcinoid].
    Banzo J; Razola P; Prats E; Freile E; Benito JL; García López F; García Tirado J; Abós MD
    Rev Esp Med Nucl; 1999; 18(2):99-103. PubMed ID: 10352322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo response to growth hormone-releasing peptide-6 in adrenocorticotropin-dependent Cushing's syndrome by lung carcinoid tumor is associated with growth hormone secretagogue receptor type 1a mRNA expression.
    Machado MC; Sá SV; Goldbaum TS; Catania M; Campos VC; Corrêa-Giannella ML; Giannella-Neto D; Salgado LR
    J Endocrinol Invest; 2007 Apr; 30(4):334-40. PubMed ID: 17556872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An unusual case of thymic carcinoid causing Cushing's syndrome due to ectopic ACTH secretion detected by (18)F-FDG PET/CT.
    Treglia G; Giovanella L; Lococo F; Bertagna F
    Rev Esp Med Nucl Imagen Mol; 2014; 33(4):253-4. PubMed ID: 24388589
    [No Abstract]   [Full Text] [Related]  

  • 11. Cyclical Cushing's syndrome due to an atypical thymic carcinoid.
    Meinardi JR; van den Berg G; Wolffenbuttel BH; Kema IP; Dullaart RP
    Neth J Med; 2006 Jan; 64(1):23-7. PubMed ID: 16421439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Whole body and tomographic scan with 111In-pentetreotide: preliminary data.
    Gregianin M; Macrì C; Bui F; Varotto L; Zucchetta P
    Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):124-6. PubMed ID: 9002769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Thymic carcinoid tumor causing paraneoplastic Cushing syndrome. Diagnostic value of double-labelled tomoscintigraphy].
    Matejka G; Toubeau M; Bernard A; Belleville Y; Vaillant G; Brun JM
    Presse Med; 1996 Sep; 25(26):1201-2. PubMed ID: 8949624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful use of 111In-pentetrotide scintigraphy for localizing ectopic adrenocorticotropin-producing bronchial carcinoid tumor in a patient with Cushing's syndrome.
    Kishida K; Moriwaki M; Miyagawa J; Okita K; Kondo T; Itoh K; Umemura S; Kozawa J; Iwahashi H; Yoshizumi T; Imagawa A; Yamagata K; Maruyama T; Toyoshima H; Kurokawa E; Funahashi T; Matsuzawa Y
    Intern Med; 2003 Oct; 42(10):996-1005. PubMed ID: 14606715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cushing's syndrome associated with a chemodectoma and a carcinoid tumour.
    Tremble JM; Buxton-Thomas M; Hopkins D; Kane P; Bailey D; Harris PE
    Clin Endocrinol (Oxf); 2000 Jun; 52(6):789-93. PubMed ID: 10848885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Focal myocardial uptake in a patient with carcinoid tumor by indium-111-pentetreotide on SPECT/CT.
    Mahmood S; Martínez de Llano SR; Grewal RK
    Rev Esp Med Nucl; 2008; 27(5):355-7. PubMed ID: 18817665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Shift from CRH to ACTH production in a thymic carcinoid with Cushing's syndrome.
    Ozawa Y; Tomoyasu H; Takeshita A; Shishiba Y; Yamada S; Kovacs K; Matsushita H
    Horm Res; 1996; 45(6):264-8. PubMed ID: 8793519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary neuroendocrine carcinoma of thymus: a rare cause of Cushing's syndrome.
    Arora R; Gupta R; Sharma A; Dinda AK
    Indian J Pathol Microbiol; 2010; 53(1):148-51. PubMed ID: 20090249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple endocrine neoplasia type I and Cushing's syndrome due to an aggressive ACTH producing thymic carcinoid.
    Takagi J; Otake K; Morishita M; Kato H; Nakao N; Yoshikawa K; Ikeda H; Hirooka Y; Hattori Y; Larsson C; Nogimori T
    Intern Med; 2006; 45(2):81-6. PubMed ID: 16484744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paraneoplastic ACTH secretion: bronchial carcinoid overlooked by planar indium-111 pentetreotide scintigraphy and accurately localized by SPECT/CT acquisition.
    Aide N; Reznik Y; Icard P; Franson T; Bardet S
    Clin Nucl Med; 2007 May; 32(5):398-400. PubMed ID: 17452874
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.